Siltussin Dm Das Cough Formula
NDC Package 17856-0134-2

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Siltussin Dm Das Cough Formula is take every 4 hours, or as directed by a doctor do not take more than 6 doses in 24 hours Adults and children 12 years and over 2 teaspoonfuls (TSP)(10 mL)Children under 12 yearsDO NOT USEOther informationstore at room temperature between 15°-30°C (59°-86°F). Marketed by Altantic Biologicals Corp., this product is identified by NDC 17856-0134 and is authorized under FDA application part341.

Identification & Billing

NDC Package Code
17856-0134-2
Package Description
72 CUP, UNIT-DOSE in 1 BOX, UNIT-DOSE / 10 mL in 1 CUP, UNIT-DOSE
Product Code
11-Digit Billing Format
17856013402
RxNorm Crosswalk
  • RxCUI: 996520 - dextromethorphan HBr 20 MG / guaiFENesin 200 MG in 10 mL Oral Solution
  • RxCUI: 996520 - dextromethorphan hydrobromide 2 MG/ML / guaifenesin 20 MG/ML Oral Solution
  • RxCUI: 996520 - dextromethorphan hydrobromide 10 MG / guaifenesin 100 MG per 5 ML Oral Solution
  • RxCUI: 996520 - dextromethorphan hydrobromide 15 MG / guaifenesin 150 MG per 7.5 ML Oral Solution
  • RxCUI: 996520 - dextromethorphan hydrobromide 20 MG / guaifenesin 200 MG per 10 ML Oral Solution

Clinical Specifications

Proprietary Name
Siltussin Dm Das Cough Formula
Dosage Form
-
Usage Information
Take every 4 hours, or as directed by a doctor do not take more than 6 doses in 24 hours Adults and children 12 years and over 2 teaspoonfuls (TSP)(10 mL)Children under 12 yearsDO NOT USEOther informationstore at room temperature between 15°-30°C (59°-86°F)

Regulatory & Marketing

Labeler Name
Altantic Biologicals Corp.
FDA Application #
part341
Marketing Category
OTC MONOGRAPH FINAL - A product marketed pursuant to a final Over-the-Counter (OTC) Drug Monograph.
Start Marketing Date
09-05-1995
Listing Expiration
12-31-2021
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (17856-0134). Click a package code to view its specific billing and regulatory data.

72 CUP, UNIT-DOSE in 1 BOX, UNIT-DOSE / 5 mL in 1 CUP, UNIT-DOSE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 17856-0134-2 identifies a specific commercial package of 72 cup, unit-dose in 1 box, unit-dose / 10 ml in 1 cup, unit-dose of Siltussin Dm Das Cough Formula, labeled by Altantic Biologicals Corp.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Altantic Biologicals Corp. on September 05, 1995. The current certification is valid through December 31, 2021.

How is this Altantic Biologicals Corp. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 17856013402. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
17856-0134-2
11-Digit CMS (5-4-2)
17856-0134-02

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.